Testicular carcinoma metastatic to the neck is rare. Even more rare is a finding of choriocarcinoma as a neck mass without any sign of a primary testicular tumor, as only a few cases have been reported in the literature. We describe a new case that occurred in a 29-year-old man who presented with a neck mass. Fine-needle aspiration biopsy identified the tumor as a malignant epithelial neoplasm. Radiologic findings indicated the presence of a systemic metastasis of a tumor to the chest and abdomen, as well as the neck. Findings on an incisional biopsy of the neck mass were consistent with a choriocarcinoma. The testicles were normal on palpation and ultrasonography. The patient was diagnosed with metastatic choriocarcinoma with an unknown primary, and he was started on chemotherapy. On the second day of treatment, which was 25 days after his referral to our clinic, he died of respiratory insufficiency.
Introduction
Carcinoma of the testicle is the most common malignancy in men between the ages of 15 and 34 years. 1 This malignancy usually presents as an enlargement of the testicle or as a mass in the testicle. 2 Germ cell tumors account for 98% of all testicular malignancies. 1 Choriocarcinoma is a rare, highly malignant tumor of the testes, and it usually occurs as a component of mixed germ cell tumor. 3 The incidence of testicular carcinoma metastatic to the neck has been reported to be 5%. 3 Even more uncommon is a finding of choriocarcinoma as a neck mass without any sign of a primary testicular tumor, as only a few such cases have been published in the literature. 3 In this article, we report a new case.
Case report
A 29-year-old man was referred to our ENT clinic with a painless mass in the left side of his neck of 1 month's duration. The patient reported that the mass had enlarged rapidly during the previous week and that it had become tender over the previous several days. He denied sore throat, hoarseness, and difficulty breathing or swallowing. He also denied weight loss and generalized fatigue. He did not consume alcohol, but he had been smoking for 10 years. The remainder of his medical history was unremarkable. He had been given an oral antibiotic at the referring center, but it had had no effect on the mass.
On examination, the mass measured 7 × 8 cm, and it was firm and tender. The mass occupied the middle and lower cervical levels on the left side of the neck, and it extended to the midline of the neck anteriorly, to the posterior triangle of the neck posteriorly, and to the clavicle inferiorly. It was fixed to deep cervical tissues and tender on deep palpation. Findings on the rest of the ENT and systemic physical examinations were normal.
Contrast-enhanced computed tomography (CT) of the neck demonstrated a 7.5 × 5.5 × 4.5-cm mass deep to the sternocleidomastoid muscle in the left infrahyoid compartment; the mass exhibited nodular contrast enhancement in the early arterial phase (figure 1). Based on this finding, carotid and cerebral angiography was performed, and it identified a hypervascular mass with its blood supply coming from the left external carotid artery, the left vertebral artery, and the left subclavian artery. Angiography also detected a decrease in the calibration of the proximal part of the left vertebral artery, indicating the possibility of tumor invasion.
An ultrasonography-guided fine-needle aspiration biopsy (FNAB) of the mass was performed. The cytologist reported it as a malignant epithelial neoplasm. Immunocytochemical studies showed that the neoplastic cells were positive for pancytokeratin and negative for vimentin, p63, and CD30. These findings are consistent with a high-grade carcinoma, and they first suggested to us a diagnosis of squamous cell carcinoma.
Because of the absence of any focus of primary malignancy in the head and neck region, we obtained chest and abdominal CT scans to look for a primary tumor in those regions. The chest CT findings were reported as "conglomerated lymphadenopathies in [the] left supraclavicular region, multiple mediastinal and hilar lymphadenopathies, [and] multiple nodules in the lung (metastasis or involvement by lymphoma?)" (figure 2). The chest x-ray also revealed multiple metastatic nodules in the lung (figure 3). The abdominal CT was reported as "multiple retrocrural paraaortic metastatic lymphadenopathies [and] multiple metastases in the base of the lung. "
An incisional biopsy of the neck mass was obtained. The lesion was identified as a "germ cell tumor metastasis (consistent with choriocarcinoma metastasis). " On immunohistochemical studies, the neoplastic cells were positive for beta-human chorionic gonadotropin (β-hCG), cytokeratin, and focal epithelial membrane antigen and negative for placental alkaline phosphatase, alpha-fetoprotein (AFP), thyroglobulin, and vimentin. Giant cells in the sample were positive for inhibin.
The tumor had a relatively homogeneous appearance, with tumor cells exhibiting clear cytoplasm that suggested cytotrophoblasts and scattered multinucleated giant cells that suggested syncytiotrophoblasts (figure 4, A and B). The neoplastic cells had prominent mitotic activity and focal necrosis. Immunohistochemical studies showed diffuse positive staining of tumor cells with β-hCG (figure 4, C) and focal positivity with inhibin (figure 4, D). Immunohistochemical studies confirmed the trophoblastic nature of the cells and clinched the diagnosis as a metastatic choriocarcinoma (stage III).
The testicles were reexamined carefully by palpation and ultrasonography, and no sign of a testicular tumor was detected. Serology revealed that while the serum levels of AFP and carcinoembryogenic antigen (CEA) were normal, the level of β-hCG was markedly high. The AFP level was 5.1 IU/ml (normal: 0 to 5.8); the CEA level was 0.55 ng/ml (normal: 0 to 4.3); and the β-hCG level exceeded 10,000 IU/ml (normal: 0 to 10). The patient was diagnosed with a "neck metastasis of choriocarcinoma with [an] unknown primary site. "
The patient was started on a cisplatin/etoposide chemotherapy protocol. However, on the second day of the first course of chemotherapy, he began to experience difficulty breathing. The chemotherapy was stopped immediately, and methotrexate therapy was initiated. The patient was then taken to the intensive care unit, intubated, and mechanically ventilated. Within a few hours, he experienced cardiopulmonary arrest, and he died despite resuscitation 25 days after he had been referred to our clinic. No autopsy was performed.
Discussion
Metastases to the neck from non-head/neck primary tumors are rare. When they do occur, they pose important diagnostic and therapeutic challenges for head and neck surgeons. 4 Tumors that arise in other parts of the body or from an unknown primary site can present with cervical lymphadenopathy. If metastasis is not considered, then the diagnosis may be delayed. 4 A small number of patients will not have an identifiable primary tumor, even after a full clinical evaluation and random biopsies, and these cases are classified as a metastasis from an unknown primary. 4 A primary tumor will subsequently be identified in approximately 25% of these patients. [5] [6] [7] Urogenital primaries. Of all the tumors metastatic to the head and neck from distant primaries, urogenital tract neoplasms make up a significant proportion, and they should be considered in the differential diagnosis of neoplastic lesions of the head and neck. 8 Urogenital tumors are the third most common of the malignancies known to metastasize to the supraclavicular fossa. 4 • Recently, Ogunyemi et al studied 734 cases of metastatic head and neck cancer and found that 37 of these (5.0%) occurred in patients with a primary genitourinary cancer. 9 • In 1986, Hessan et al reviewed a series of 845 urogenital tumors and found that 31 (3.7%) had metastasized to the head and neck; 21 of them (2.5%) had metastasized to the cervical lymph nodes. 8 • According to Batsakis, renal cell carcinoma metastasizes to the head and neck by hematogenous and lymphatic routes. 10 • Jakobsen et al found that approximately 15% of patients with renal cell carcinoma develop an extracranial head and neck metastasis. 5 • Brener et al reported a case of renal cell carcinoma metastatic to the thyroid gland, nose, and skull base (in addition to the small intestine). 11 • Ferlito et al reported that the thyroid is the most common head/neck site of metastasis from renal cell carcinoma. 4 • Prostate cancer can metastasize to the cervical lymph nodes, 8 particularly to the supraclavicular nodes. 4, 12 Indeed, prostate cancer has been found to spread to almost all of the structures in the head and neck. A case of prostate cancer that metastasized to the external auditory canals bilaterally was recently reported by Shrivastava et al. 13 • Urinary bladder carcinoma is associated with a very low rate of metastasis to the cervical lymph nodes. 4 • Endometrial carcinoma is known to metastasize to the supraclavicular lymph nodes, 4 but ovarian carcinoma does so only infrequently. 8 Testicular cancers. Tumors of the testes are classified into two broad categories: seminomas and nonseminomatous germ cell tumors. 14 Choriocarcinoma is a highly malignant but uncommon nonseminomatous germ cell tumor of the testes. 3 In 10 to 20% of cases, patients present with metastatic disease, although in some of these cases the primary tumor remains clinically occult. 2 The most common sites of metastasis of testicular germ cell tumors are the retroperitoneal lymph nodes, lungs, and liver. 2, 3 • In 1973, Flocks and Boatman categorized genitourinary malignancies according to the incidence of head and neck metastasis. 15 They found that 13% of testicular malignancies metastasized to the head and neck region.
• In 1984, Sugano et al reported a case of choriocarcinoma that had metastasized to the submental area and resulted in death. 16 • In 2004, Akst et al reported that the incidence of testicular carcinoma metastatic to the neck ranged from 4.5 to 15%. 1 In an estimated 5% of these cases, the neck mass was the initial sign. Cases of such a phenomenon as occurred in our patient are very rare, especially when they involve a choriocarcinoma. Romero et al described the case of a patient with testicular choriocarcinoma who presented with a supraclavicular mass as the initial sign. 17 That patient received four courses of polychemotherapy, and he remained alive and well 6 months after diagnosis. In our case, we could not find a primary carcinoma focus in the testicles by palpation or ultrasonography.
On gross examination, choriocarcinomas of the testes are often small, and the involved testis may appear normal. 3 This is one possible reason that we could not find a primary tumor in our patient (we did not perform an autopsy to look for a testicular focus). Another possible reason is that the primary tumor might have been an extragonadal choriocarcinoma, which by definition does not involve the testicles.
All germ cell tumors have a propensity for lymphatic spread, but nonseminomatous germ cell tumors are much more likely to demonstrate hematogenous spread. 1 Hematogenous spread is a well-known characteristic of choriocarcinoma. 18 The most common sites of systemic metastasis of choriocarcinoma are the lungs, liver, brain, and bony skeleton. 14, 18 The skin is rarely involved in metastasis. 18 Metastases of testicular tumors to the lymphatic system tend to be contiguous, spreading from the abdomen into the chest and finally into the neck. 1 The typical lymphatic spread initially involves the retroperitoneal, paraaortic, mediastinal, and supraclavicular lymph nodes sequentially. 14 Cervical metastases from germ cell tumors are almost always found within the left supraclavicular fossa, as occurred in our case. [1] [2] [3] 14 For this reason, a finding of a supraclavicular mass in a man between the ages of 20 and 35 years should prompt an examination for a testicular mass. 4 Diagnosis. The definitive diagnosis of a neck metastasis of choriocarcinoma is based on histopathologic examination and immunocytochemical staining. The first step is FNAB. The diagnostic accuracy of FNAB for metastatic carcinomas in a lymph node is roughly 90 to 95%. 2 The cytologic features of germ cell tumors are less specific, and they cannot be distinguished from those of other poorly differentiated malignancies such as carcinoma, melanoma, and lymphoma. 2 Therefore, FNAB might not provide enough information about true nature of the mass, as occurred in our case. In such a situation, the clinician should consider an excisional biopsy if possible. If one is not possible or if a complete removal of the mass is dangerous because of the proximity of adjacent vital structures, an incisional biopsy can be carried out.
Choriocarcinomas consist of two basic cell types: cytotrophoblasts and β-hCG-positive syncytiotrophoblasts. 18 The presence of multinucleated syncytiotrophoblastic giant cells is very characteristic of choriocarcinomas, but these cells can also be seen in seminomas, as well as in mixed germ cell tumors. 2 In immunocytochemical studies, β-hCG positivity in syncytiotrophoblastic giant cells is an important finding. 2, 3, 18 Serologic tumor markers, such as elevated serum β-hCG and AFP levels, facilitate the identification of germ cell tumors. 2 These markers are crucial in detecting residual or recurrent germ cell tumors during follow-up .
Treatment. Choriocarcinomas should be treated aggressively with chemotherapy and/or surgery because they are potentially curable. 2 Cisplatin-based chemotherapy improves the prognosis. 2 Likewise, surgery after chemotherapy improves the prognosis in a surprisingly large number of young men with systemically disseminated disease; their 5-year survival is approximately 80%. 2 Overall cure rates for germ cell tumors are in the neighborhood of 90 to 95%. 1 Obviously, maintenance of these high rates depends on prompt diagnosis and treatment.
The presence of cervical lymph node involvement is believed to be a marker for advanced disease. Our patient had a stage III tumor, and he was started on chemotherapy as soon as possible. Despite aggressive treatment, however, he died as a result of pulmonary insufficiency 25 days after his initial presentation because his disease was very aggressive and disseminated.
In conclusion, testicular tumors should be considered in the differential diagnosis of a young man who presents with a neck mass, especially a mass in the left supraclavicular fossa. Otolaryngologists should remember that prompt diagnosis and treatment of neck masses can be life saving and result in longer patient survival.
